Turing Pharmaceuticals LLC is facing a backlash after raising the price of Daraprim to $750 per tablet, now Imprimis Pharmaceuticals, Inc. is offering an alternative at a price of less than one dollar per tablet.
By H. Nelson Goodson
Hispanic News Network U.S.A.
October 23, 2015
San Diego, CA – On Thursday, Imprimis Pharmaceuticals, Inc. announced that it will offer a customized formulation of pyrimethamine and leucovorin to doctors to prescribe to patients as an alternative to Daraprim. Daraprim is sold by Turing Pharmaceuticals LLC for $750 per tablet and Imprimis will make it available for less than one dollar per tablet or $99.00 per one hundred tablets.
According to a news release by Imprimis, last month, Turing Pharmaceuticals LLC, the sole supplier of Daraprim, increased the price of this prescription drug from $13.50 per tablet to a reported $750.00 per tablet. The FDA-approved label for Daraprim indicates that it is prescribed for toxoplasmosis and other types of infections. Toxoplasmosis can be of major concern for patients with weakened immune systems such as patients with HIV/AIDS, pregnant women and children. According to the Centers for Disease Control and Prevention, pyrimethamine works to block folic acid synthesis in the parasite T. gondii, the cause of toxoplasmosis, and leucovorin helps to reverse the negative effects on bone marrow caused by this mechanism of action.
Imprimis is now offering customizable compounded formulations of pyrimethamine and leucovorin in oral capsules starting as low as $99.00 for a 100 count bottle, or at a cost of under a dollar per capsule, Imprimis Pharmaceuticals reported.